TRACY HILBURN: Open Payments
NPI 1659725430 · GREENCASTLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,647 in 84 payments from 24 companies in 2025. Trend: 2023 $574 · 2024 $1,473 · 2025 $1,647
Food & beverage: $1,647
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $303 |
| Novo Nordisk Inc | 11 | $233 |
| Otsuka America Pharmaceutical, Inc. | 7 | $141 |
| AstraZeneca Pharmaceuticals LP | 6 | $135 |
| Axsome Therapeutics, Inc. | 4 | $109 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $108 |
| Lilly USA, LLC | 6 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $73 |
| Amgen Inc. | 4 | $62 |
| Electromed, Inc. | 2 | $52 |
Products named: REXULTI, VRAYLAR, Auvelity, CAPLYTA, Rybelsus, QULIPTA, MOUNJARO, Kerendia.
Industry payments across IN — which companies pay providers there.
